Second batch of Sputnik V Vaccine reaches

60,000 doses of Russia’s C-19 vaccine Sputnik V landed at Rajiv Gandhi International Airport here, Dr Reddy’s Laboratories said.

“Pleased to share that the consignment that arrived today in Hyderabad contains 60,000 doses of the second dose component of the Sputnik V vaccine. Samples from the consignment will be sent for release to the Central Drugs Laboratory (CDL),” the company tweeted.

On May 14, Dr Reddy’s Laboratories soft-launched the Sputnik V vaccine which is priced at Rs 948, with five per cent GST per dose (retail price).

“Given the recent launch of the Russian vaccine in the Indian vaccination campaign, this second delivery has become very timely. The efficacy of the Sputnik V is well-known in the world,” Nikolay Kudashev Russian Ambassador to India tweeted.

The first consignment of 1.50 lakh doses of Sputnik V vaccine from the Russian Direct Investment Fund (RDIF) landed in India on May 1, and received regulatory clearance from the Central Drugs Laboratory.

Dr Reddy’s had earlier said these consignments will be used across different channels as a pilot to line up the supply chain for the larger vaccination programme rollout.

Related Posts

Unapproved drops for dry eyes pose risks: Govt

NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Govt highlights multi-layer framework to curb misleading advertisements

Govt highlights multi-layer framework to curb misleading advertisements

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Study finds rising resistance to a last-resort antibiotic in Africa

Study finds rising resistance to a last-resort antibiotic in Africa